Desert Ridge Allergy Associates

https://jamanetwork.com/journals/jama/fullarticle/2847972?guestAccessKey=825c3f95-36ef-4a6b-bd07-2b1b9efa9fa2&utm_source=fbpage&utm_medium=social_jama&utm_term=20515907451&utm_campaign=article_alert&linkId=944564150&fbclid=IwY2xjawR5setleHRuA2FlbQIxMABicmlkETFUNGdiSHZqMFVUN0p6UDhMc3J0YwZhcHBfaWQQMjIyMDM5MTc4ODIwMDg5MgABHpVxijwXFDs1vXIrjAZFbMsb8BMJiIGFmp7zuA9i2mYcxy6dqoM43bjexT3e_aem_a-5HsaQpxIveDI2DC8p3TQ

Amoxicillin-Clavulanate vs Amoxicillin for Acute Sinusitis in Adults This retrospective cohort study examines treatment failure and adverse events in standard-dose amoxicillin compared with amoxicillin-clavulanate in adults with acute sinusitis.

https://www.aap.org/en/news-room/news-releases/aap/2025/statement-by-aap-president-susan-j.-kressly-md-faap-on-changes-to-cdcs-website-on-autism

Statement by AAP President Susan J. Kressly, MD, FAAP on Changes to CDC’s Website on Autism “The Centers for Disease Control and Prevention website has been changed to promote false information suggesting vaccines cause autism. Since 1998, independent researchers across seven countries have conducted more than 40 high-quality studies involving over 5.6 million people. The conclusion is c...

https://www.hcplive.com/view/fda-approves-dupilumab-dupixent-for-chronic-spontaneous-urticaria?fbclid=IwY2xjawJvyllleHRuA2FlbQIxMQABHu6wk2E4kbgGIfg-HaoZ1UuYpGtQd84pN2_-cpQfmAu1vSf7f2bmcbFebblI_aem_RwuSekeuAGW9JWAf5sBNsg

FDA Approves Dupilumab (Dupixent) for Chronic Spontaneous Urticaria Dupilumab's approval marks the first new, targeted therapy for CSU in more than a decade and is the 7th indication for a disease with underlying type 2 inflammation.

https://www.allergicliving.com/2025/04/11/xolair-rival-aims-for-food-allergy-dosing-of-every-2-to-3-months/

Xolair Rival Aims for Food Allergy Dosing of Every 2 to 3 Months Rapt’s anti-IgE therapy RPT904 may prove a rival to Xolair for multiple . In an early study, only required shots 2–3 months.

https://apple.news/A21W2FkisRCeemAM40kmLBg

Discontinuation of popular asthma medication linked with increased hospitalization — ABC News "The system is really getting in the way," said a pediatric pulmonologist.

https://l.facebook.com/l.php?u=https%3A%2F%2Fwww.fda.gov%2Fnews-events%2Fpress-announcements%2Ffda-approves-first-nasal-spray-treatment-anaphylaxis%3Ffbclid%3DIwZXh0bgNhZW0CMTEAAR1YKeDIl0GFoJWS5U--V-DB7b8RY6Z4hzYzqZ_V8mF6boiK6t7jLCLQjjE_aem_vRXwn1J5A0x7RX-3agsxHQ&h=AT1NRdw4gDPTSvzUaaP_MQbqCpPn6rQCksNDoemHjLqXDq4apDZxDanf7PnGSx0-omhq-bRC3QWflHHlLoNGG1rTvoIaXNDIjH8pwacBA1zvxcGRBdacpE3Z3AgLA2MuRsOsy0g&__tn__=H-R&c[0]=AT3k5wm98ZTKJh # # -Fs_yev_waCrFXapgPyK7GYomgSx-nmhQclC6G6-HUwo3j5TxRGIVfeOqqaqCtgXsZtdGEXLwvt6IJykn18t1x7UlEz8BiAwS-7yTP6vGN7x7bfo9p5zmNnLDkY41kVTpPxrpHdlvEo_KR0oxgBNRJpJ7Om5nDDBoS_GSileHxAS27ypCmFNE_pVEV4

FDA Approves First Nasal Spray for Treatment of Anaphylaxis The FDA approved the first nasal spray for the emergency treatment of allergic reactions in adult and certain pediatric patients.

Just a reminder that the office is closed January 1 - 3, 2024. Normal hours resume January 4. Thank you. We wish you a healthy happy new year.

New COVID Vaccine boosters expected in September. Stay tuned.

US to Offer Updated COVID Booster Shots in September With the new shots on the way, federal officials have decided not to expand eligibility for second boosters of the existing vaccines for those under age 50 years this summer.

https://www.businesswire.com/news/home/20220712005124/en/Astepro®-Allergy-First-and-Only-Steroid-Free-Antihistamine-Nasal-Spray-Now-Available-Over-the-Counter?fbclid=IwAR0_deyZuBlIc_yfDPutEMyqYyTzpNsn5oWe-yoQQa7PdnwAn19VBf_7qLQ

We now have COVID vaccines in stock for adults and children from age 6 months